{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T10:54:08Z","timestamp":1753181648616,"version":"3.37.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T00:00:00Z","timestamp":1657238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T00:00:00Z","timestamp":1657238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Drug Metab Pharmacokinet"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s13318-022-00781-w","type":"journal-article","created":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T20:02:22Z","timestamp":1657310542000},"page":"687-697","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["External Validation of a Vancomycin Population Pharmacokinetic Model and Developing a New Dosage Regimen in Neonates"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2088-2632","authenticated-orcid":false,"given":"Chuan Poh","family":"Lim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng Hsuan","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4504-8257","authenticated-orcid":false,"given":"Cheryl Chia Chin","family":"Neoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woei Bing","family":"Poon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,8]]},"reference":[{"key":"781_CR1","doi-asserted-by":"publisher","first-page":"170","DOI":"10.4161\/viru.26906","volume":"2014","author":"BA Shah","year":"2014","unstructured":"Shah BA, Padbury JF. Neonatal sepsis: an old problem with new insights. Virulence. 2014;2014:170\u20138.","journal-title":"Virulence"},{"issue":"1","key":"781_CR2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/S0146-0005(98)80003-7","volume":"22","author":"RL Schelonka","year":"1998","unstructured":"Schelonka RL, Infante AJ. Neonatal immunology. Semin Perinatol. 1998;22(1):2\u201314.","journal-title":"Semin Perinatol"},{"key":"781_CR3","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.jpeds.2012.11.089","volume":"162","author":"NS Boghossian","year":"2013","unstructured":"Boghossian NS, Page GP, Bell EF, Stoll BJ, Murray JC, Cotten CM, Shankaran S, Walsh MC, Laptook AR, Newman NS, Hale EC, McDonald SA, Das A, Higgins RD. Late-onset sepsis in very low birth weight infants from singleton and multiple-gestation births. J Pediatr. 2013;162:1120\u20134.","journal-title":"J Pediatr"},{"key":"781_CR4","doi-asserted-by":"crossref","unstructured":"Shane AL, Hansen NI, Stoll BJ, Bell EF, Sanchez PJ, Shankaran S, Laptook AR, Das A, Walsh MC, Hale EC, Newman NS, Schrag SJ, Higgins RD. Methicillin-resistant and susceptible Staphylococcus aureus bacteremia and meningitis in preterm infants. Pediatrics. 2012;129:e914\u201322.","DOI":"10.1542\/peds.2011-0966"},{"key":"781_CR5","doi-asserted-by":"crossref","unstructured":"Nelson MU, Gallagher PG. Methicillin-resistant Staphylococcus aureus in the neonatal intensive care unit. Semin Perinatol. 2012;36:424\u201330.","DOI":"10.1053\/j.semperi.2012.06.004"},{"key":"781_CR6","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1542\/peds.110.2.285","volume":"110","author":"BJ Stoll","year":"2002","unstructured":"Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, Lemons JA, Donovan EF, Stark AR, Tyson JE, Oh W, Bauer CR, Korones SB, Shankaran S, Laptook AR, Stevenson DK, Papile LA, Poole WK. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics. 2002;110:285\u201391.","journal-title":"Pediatrics"},{"key":"781_CR7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.siny.2012.10.003","volume":"18","author":"E Jacqz-Aigrain","year":"2013","unstructured":"Jacqz-Aigrain E, Zhao W, Sharland M, van den Anker JN. Use of antibacterial agents in the neonate: 50 years of experience with vancomycin administration. Semin Fetal Neonatal Med. 2013;18:28\u201334.","journal-title":"Semin Fetal Neonatal Med"},{"issue":"1","key":"781_CR8","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1086\/491708","volume":"42","author":"RC Moellering Jr","year":"2006","unstructured":"Moellering RC Jr. Vancomycin: a 50-year reassessment. Clin Infect Dis. 2006;42(1):S3\u20134.","journal-title":"Clin Infect Dis"},{"key":"781_CR9","doi-asserted-by":"publisher","first-page":"F438","DOI":"10.1136\/archdischild-2013-305900","volume":"99","author":"C Pansieri","year":"2014","unstructured":"Pansieri C, Bonati M, Choonara I, Jacqz-Aigrain E. Neonatal drug trials: impact of EU and US paediatric regulations. Arch Dis Child Fetal Neonatal Ed. 2014;99:F438.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"781_CR10","doi-asserted-by":"crossref","unstructured":"Rybak MJ, Le J, Lodise TP, Levine DP, Bradley JS, Liu C, et al. Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Am J Health-Syst Pharm. 2020;77:835\u201364.","DOI":"10.1093\/ajhp\/zxaa036"},{"key":"781_CR11","doi-asserted-by":"crossref","unstructured":"Moise-Broder PA, Forrest A, Birmingham MC, Schentag JJ. Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections. Clin Pharmacokinet. 2004;43:925\u201342.","DOI":"10.2165\/00003088-200443130-00005"},{"key":"781_CR12","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1128\/AAC.03147-14","volume":"60","author":"R Alvarez","year":"2016","unstructured":"Alvarez R, Lopez Cortes LE, Molina J, Cisneros JM, Pachon J. Optimizing the clinical use of vancomycin. Antimicrob Agents Chemother. 2016;60:2601\u20139.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"781_CR13","doi-asserted-by":"publisher","first-page":"e01647","DOI":"10.1128\/AAC.01647-17","volume":"62","author":"SH Tseng","year":"2018","unstructured":"Tseng SH, Lim CP, Chen Q, Tang CC, Kong ST, Ho PC. Evaluating the relationship between vancomycin trough concentration and 24-hour area under the concentration-time curve in neonates. Antimicrob Agents Chemother. 2018;62(4):e01647-e1717.","journal-title":"Antimicrob Agents Chemother"},{"key":"781_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.623907","volume":"12","author":"YX Liu","year":"2021","unstructured":"Liu YX, Wen H, Niu WJ, Li JJ, Li ZL, Jiao Z. External evaluation of vancomycin population pharmacokinetic models at two clinical centers. Front Pharmacol. 2021;12: 623907.","journal-title":"Front Pharmacol"},{"key":"781_CR15","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/00007691-200108000-00022","volume":"23","author":"CHW Koks","year":"2001","unstructured":"Koks CHW, Crommentuyn KML, Hoetelmans RMW, Math\u00f4t RAA, Beijnen JH. Can fluconazole concentrations in saliva be used for therapeutic drug monitoring? Ther Drug Monit. 2001;23:4.","journal-title":"Ther Drug Monit"},{"key":"781_CR16","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1208\/s12248-011-9255-z","volume":"13","author":"M Bergstrand","year":"2011","unstructured":"Bergstrand M, Hooker AC, Wallin JE, Karlsson MO. Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models. AAPS J. 2011;13:2.","journal-title":"AAPS J"},{"issue":"2","key":"781_CR17","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.cmpb.2007.12.002","volume":"90","author":"E Comets","year":"2008","unstructured":"Comets E, Brendel K, Mentr\u00e9 F. Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: the npde add-on package for R. Comput Methods Programs Biomed. 2008;90(2):154\u201366.","journal-title":"Comput Methods Programs Biomed"},{"issue":"10","key":"781_CR18","doi-asserted-by":"publisher","first-page":"3878","DOI":"10.1111\/bcp.14803","volume":"87","author":"S Ryu","year":"2021","unstructured":"Ryu S, Jung WJ, Jiao Z, Chae JW, Yun HY. External evaluation of the predictive performance of seven population pharmacokinetic models for phenobarbital in neonates. Br J Clin Pharmacol. 2021;87(10):3878\u201389.","journal-title":"Br J Clin Pharmacol"},{"key":"781_CR19","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/1471-2431-13-59","volume":"13","author":"TR Fenton","year":"2013","unstructured":"Fenton TR, Kim JH. A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants. BMC Pediatr. 2013;13:59.","journal-title":"BMC Pediatr"},{"key":"781_CR20","unstructured":"Truven Health Analytics, Inc. NeoFax\u00ae [Internet]. 2021. http:\/\/neofax.micromedexsolutions.com\/neofax\/neofax.php. Accessed 13 Dec 2021."},{"key":"781_CR21","doi-asserted-by":"publisher","first-page":"e109","DOI":"10.1093\/jpids\/piu110","volume":"4","author":"J Le","year":"2015","unstructured":"Le J, Ny P, Capparelli E, Lane J, Ngu B, Muus R, Romanowski G, Vo T, Bradley J. Pharmacodynamic characteristics of nephrotoxicity associated with vancomycin use in children. J Pediatric Infect Dis Soc. 2015;4:e109\u201316.","journal-title":"J Pediatric Infect Dis Soc"},{"key":"781_CR22","first-page":"1","volume":"62","author":"EJ Zasowski","year":"2017","unstructured":"Zasowski EJ, Murray KP, Trinh TD, Finch NA, Pogue JM, Mynatt RP, Rybak MJ. Identification of vancomycin exposure-toxicity thresholds in hospitalized patients receiving intravenous vancomycin. Antimicrob Agents Chemother. 2017;62:1.","journal-title":"Antimicrob Agents Chemother"},{"key":"781_CR23","doi-asserted-by":"publisher","first-page":"221","DOI":"10.2165\/00003088-200746030-00003","volume":"46","author":"K Brendel","year":"2007","unstructured":"Brendel K, Dartois C, Comets E, Lemenuel-Diot A, Laveille C, Tranchand B, Girard P, Laffont CM, Mentre F. Are population pharmacokinetic and\/or pharmacodynamic models adequately evaluated? A survey of the literature from 2002 to 2004. Clin Pharmacokinet. 2007;46:221\u201334.","journal-title":"Clin Pharmacokinet"},{"key":"781_CR24","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/1471-2431-14-193","volume":"14","author":"FS Sinkeler","year":"2014","unstructured":"Sinkeler FS, de Haan TR, Hodiamont CJ, Bijleveld YA, Pajkrt D, Math\u00f4t RAA. Inadequate vancomycin therapy in term and preterm neonates: a retrospective analysis of trough serum concentrations in relation to minimal inhibitory concentrations. BMC Pediatr. 2014;14:193.","journal-title":"BMC Pediatr"},{"key":"781_CR25","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1128\/AAC.02214-15","volume":"60","author":"S Leroux","year":"2016","unstructured":"Leroux S, Jacqz-Aigrain E, Biran V, Lopez E, Madeleneau D, Wallon C. Clinical utility and safety of a model-based patient\u2013tailored dose of vancomycin in neonates. Antimicrob Agents Chemother. 2016;60:2039\u201342.","journal-title":"Antimicrob Agents Chemother"},{"key":"781_CR26","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3389\/fped.2019.00188","volume":"7","author":"M Tauzin","year":"2019","unstructured":"Tauzin M, Cohen R, Durrmeyer X, Dassieu G, Barre J, Caeymaex L. Continuous-infusion vancomycin in neonates: assessment of a dosing regimen and therapeutic proposal. Front Pediatr. 2019;7:188.","journal-title":"Front Pediatr"},{"key":"781_CR27","doi-asserted-by":"crossref","unstructured":"Demirel B, Imamoglu E, Gursoy T, Demirel U, Topcuoglu S, Karatekin G, Demirel U. Comparison of intermittent versus continuous vancomycin infusion for the treatment of late-onset sepsis in preterm infants. J Neonatal Perinat Med. 2015;8:149\u201355.","DOI":"10.3233\/NPM-15814103"},{"key":"781_CR28","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-2179","volume":"143","author":"A Gwee","year":"2019","unstructured":"Gwee A, Cranswick N, McMullan B, Perkins E, Bolisetty S, Gardiner K, Daley A, Ward M, Chiletti R, Donath S, et al. Continuous versus intermittent vancomycin infusions in infants: a randomized controlled trial. Pediatrics. 2019;143: e20182179.","journal-title":"Pediatrics"},{"issue":"2","key":"781_CR29","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1093\/jpids\/pix109","volume":"8","author":"A Frymoyer","year":"2019","unstructured":"Frymoyer A, Stockmann C, Hersh AL, Goswami S, Keizer RJ. Individualized empiric vancomycin dosing in neonates using a model-based approach. J Pediatric Infect Dis Soc. 2019;8(2):97\u2013104.","journal-title":"J Pediatric Infect Dis Soc"},{"key":"781_CR30","doi-asserted-by":"publisher","first-page":"6168","DOI":"10.1038\/s41598-021-85529-3","volume":"11","author":"SM Lee","year":"2021","unstructured":"Lee SM, Yang S, Kang S, Chang MJ. Population pharmacokinetics and dose optimization of vancomycin in neonates. Sci Rep. 2021;11:6168.","journal-title":"Sci Rep"},{"key":"781_CR31","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/jp.2014.232","volume":"35","author":"AS Weintraub","year":"2015","unstructured":"Weintraub AS, Carey A, Connors J, Blanco V, Green RS. Relationship of maternal creatinine to first neonatal creatinine in infants < 30 weeks gestation. J Perinatol. 2015;35:401\u201340.","journal-title":"J Perinatol"}],"container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-022-00781-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13318-022-00781-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-022-00781-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T03:45:59Z","timestamp":1661312759000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13318-022-00781-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,8]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["781"],"URL":"https:\/\/doi.org\/10.1007\/s13318-022-00781-w","relation":{},"ISSN":["0378-7966","2107-0180"],"issn-type":[{"type":"print","value":"0378-7966"},{"type":"electronic","value":"2107-0180"}],"subject":[],"published":{"date-parts":[[2022,7,8]]},"assertion":[{"value":"7 June 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that no funds, grants, or other support were received during the preparation of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The datasets generated during and\/or analyzed during the current study are available from the corresponding author on reasonable request.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Availability"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"This retrospective chart review study was in line with the principles of the Declaration of Helsinki. Approval was granted by the NHG Domain Specific Review Board.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"A waiver of informed consent was granted by the NHG Domain Specific Review Board.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}},{"value":"All authors contributed to the study conception and design. Material preparation and data collection and analysis were performed by Chuan Poh Lim and Sheng Hsuan Tseng. The first draft of the manuscript was written by Chuan Poh Lim and Sheng Hsuan Tseng. All authors commented on previous versions of the manuscript and read and approved the final manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}